Shoreline Biosciences
0 followers
Shoreline's proprietary cell therapy technology platform is based on deep expertise in iPSC differentiation methods and genetic programming of the IL-15/CISH pathway for enhanced metabolic fitness and persistence of the engineered NK Cells to improve anti-cancer activity.
Org chart
Kleanthis G. Xanthopoulos
Chairman & CEO
Kleanthis G. Xanthopoulos
Collapse
Robert Hollingsworth
Chief Scientific Officer
Scott Forrest
Chief Business Officer
Mauro P. Avanzi
Chief Medical Officer
Mohammad El-Kalay
SVP & Head of CMC
Steven Neben
VP, Alliance & Project Management
Paschalis Sideras
VP, Discovery Immunobiology
Pinky Doshi
VP, Regulatory Affairs
Steve Potter
VP, People & Culture
